AbbVie is one of America's most prominent biopharmaceutical companies, spun out of Abbott Laboratories in 2013 and built around a commercial drug portfolio of considerable scale and reach. Listed on the NYSE under the ticker ABBV, the company is perhaps best known as the maker of Humira, for many years the world's best-selling prescription medicine, though its strategic priority in recent years has been diversifying beyond Humira as biosimilar competition has eroded that franchise.
The diversification effort has been substantial. AbbVie's acquisitions of Allergan and a series of oncology and immunology assets have broadened the pipeline meaningfully, with Skyrizi and Rinvoq emerging as the next generation of growth drivers. For traders, AbbVie is an interesting combination of defensive pharmaceutical income: the company has a strong dividend track record and binary event risk around clinical trial outcomes and regulatory decisions that can move the share price sharply in either direction.
Please note this is marketing communication, not recommendation or advice.
conti dei clienti
FxPro fornisce servizi di trading online ai clienti dal 1999 e attualmente serve 173 paesi in tutto il mondo.
Premi
FxPro ha ricevuto continui riconoscimenti nel settore, aggiudicandosi ad oggi oltre 145 premi internazionali per la qualità dei suoi servizi.
Servizio clienti
Il personale del nostro servizio clienti multilingue lavora 24 ore su 24, 5 giorni su 7 per offrirti un'assistenza d'eccellenza.
Regolamentazioni del settore
FxPro opera sotto una rigorosa supervisione normativa in diverse giurisdizioni, inclusa l'autorizzazione della FCA nel Regno Unito, uno degli enti di regolamentazione finanziaria più affidabili a livello globale.
